Seven Eight Capital »

MaxLinear shares owned by Seven Eight Capital

Quarter-by-quarter ownership of MaxLinear (MXL) shares owned by Seven Eight Capital from 13F filings

Historical chart of Seven Eight Capital investment in MaxLinear

Tip: Access up to 7 years of quarterly data

All positions including MaxLinear held by Seven Eight Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in MaxLinear by Seven Eight Capital

Quarter filed Position value Share count Share price at filing
2023-09-30 $1.6M 70k 22.25
2016-06-30 $11k 600 18.33

More positions owned by Seven Eight Capital

Edwards Lifesciences (EW)
Merck & Co (MRK)
Las Vegas Sands (LVS)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl C (GOOG)
Vertex Pharmaceuticals Incorporated (VRTX)
Vertiv Holdings Com Cl A (VRT)
Intuitive Surgical Com New (ISRG)
ResMed (RMD)
Docusign (DOCU)
Fiserv (FI)
Xylem (XYL)
Meta Platforms Cl A (META)
Jabil Circuit (JBL)
Nextera Energy (NEE)

View all positions for Seven Eight Capital

Top funds holding MaxLinear

Vanguard Group
Bank of New York Mellon
PRIMECAP Management Company
Dimensional Fund Advisors
T. Rowe Price Associates
D. E. Shaw & Co
Jacobs Levy Equity Management
Voloridge Investment Management
HighTower Advisors
Charles Schwab Investment Management
Jennison Associates
Citadel Advisors
Two Sigma Advisers
Principal Financial Group
Bank of America Corporation

View all funds holding MaxLinear